Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Global Market Value Of The Hormonal Intrauterine Devices (IUDs) Industry In 2025?
The hormonal intrauterine devices (iuds) market size has grown rapidly in recent years. It will grow from $2.61 billion in 2024 to $2.87 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to the development of safer and more effective hormonal formulations, rising demand for long-term birth control solutions, increasing healthcare provider recommendations, greater public awareness of contraceptive options, and advancements in medical technology and device design.
The hormonal intrauterine devices (iuds) market size is expected to see rapid growth in the next few years. It will grow to $4.29 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to rising awareness of contraceptive choices, increasing preference for long-acting reversible contraception, advancements in device safety and efficacy, growing emphasis on personalized healthcare, and broader availability through healthcare providers. Major trends in the forecast period include advancements in device technology, increasing personalization of contraceptive options, growth in patient-centric healthcare approaches, rising demand for sustainable and eco-friendly products, development of new contraceptive products.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp
Which Major Market Drivers Are Shaping The Future Of The Hormonal Intrauterine Devices (IUDs) Market?
The increase in unwanted pregnancies is expected to propel the growth of the hormonal intrauterine devices market going forward. Unwanted pregnancies refer to pregnancies that are not planned or desired at the time of conception. These pregnancies can occur for various reasons, including contraceptive failure, lack of access to birth control, incorrect use of contraception, or sexual violence. Limited access to effective contraception increases the risk of unwanted pregnancies by reducing individuals’ control over their reproductive choices. Hormonal IUDs are highly effective at preventing pregnancy, with a failure rate of less than 1%. They provide long-term protection (3 to 7 years, depending on the type) and are a reliable option for those seeking to avoid unwanted pregnancies. For instance, in August 2023, according to the Office for Health Improvement & Disparities, a UK-based governmental unit within the UK’s Department of Health and Social Care, from January to June 2022, residents of England and Wales had 123,219 abortions, marking a 17% increase compared to the same period in 2021. Therefore, the increase in unwanted pregnancies is driving the growth of the hormonal intrauterine devices market.
What Are The Major Segment Types Covered In The Hormonal Intrauterine Devices (IUDs) Market?
The hormonal intrauterine devices (iuds)market covered in this report is segmented –
1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices
2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices
3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices
4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications
Subsegments:
1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions
2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions
3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis
How Are Trends Influencing The Hormonal Intrauterine Devices (IUDs) Market?
Major companies operating in the hormonal intrauterine devices market are focused on developing advanced products, such as levonorgestrel-releasing intrauterine systems, to provide more personalized contraceptive solutions for women. Levonorgestrel-releasing intrauterine systems (LNG-IUS) are hormonal intrauterine devices that release a steady dose of levonorgestrel, a synthetic progestin, into the uterus. This hormone thickens cervical mucus and alters the uterine lining to prevent sperm from reaching the egg. For instance, in November 2022, Medicines360, a US-based pharmaceutical organization focused on improving women’s access to essential medicines and health products, introduced the U.S. Food and Drug Administration (FDA)-approved LILETTA. LILETTA is one of the longest-lasting hormonal IUDs in the U.S. and is approved for up to 8 years of contraception and up to 5 years for treating heavy menstrual bleeding. It is approximately 99% effective in preventing pregnancy across diverse populations. The device features an ergonomic inserter for easy placement on the same day as a consultation and can be removed at any time by a healthcare provider. It is available by prescription, and LILETTA is offered at a reduced cost through the 340B drug pricing program, supporting Medicines360’s mission to improve access to women’s healthcare.
Which Key Players Are Driving Competition In The Hormonal Intrauterine Devices (IUDs) Market?
Major companies operating in the hormonal intrauterine devices (IUDs) market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Bharat Serums and Vaccines Limited, Teva UK Limited, EurimPharm Produktions GmbH, HRA Pharma SAS, Medicines360, Hll Lifecare Limited, Pregna International Ltd., Allergan plc, Actavis Inc., DKT WomanCare Global, CrossBay Medical Inc., SMB Corporation of India, Oy Leiras, OCON Healthcare
Download The Full Report For Exclusive Market Findings:
What Regional Growth Trends Are Shaping The Hormonal Intrauterine Devices (IUDs) Market Outlook?
North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (IUDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Hormonal Intrauterine Devices (IUDs) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=19091&type=smp
Browse Through More Reports Similar to the Global Hormonal Intrauterine Devices (IUDs) Market 2025, By The Business Research Company
Hormonal Contraceptives Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report
Drugs For Hormonal Replacement Therapy Global Market Report 2025
Handheld Surgical Devices And Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model